Clinical Trial Update: Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigates using sacubitril/valsartan to treat heart dysfunction related to cancer therapy; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Dysfunction
• Heart Failure

Drugs mentioned

• Sacubitril/valsartan (Entresto) (sacubitril/valsartan)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Heart Failure, Heart Dysfunction | Phase 1, Phase 2 | Status: RECRUITING